Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4569405
Max Phase: Preclinical
Molecular Formula: C52H44O20P4S4
Molecular Weight: 1241.07
Molecule Type: Unknown
Associated Items:
ID: ALA4569405
Max Phase: Preclinical
Molecular Formula: C52H44O20P4S4
Molecular Weight: 1241.07
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=P(O)(Cc1cc2c(O)c(c1)S(=O)(=O)c1cc(CP(=O)(O)c3ccccc3)cc(c1O)S(=O)(=O)c1cc(CP(=O)(O)c3ccccc3)cc(c1O)S(=O)(=O)c1cc(CP(=O)(O)c3ccccc3)cc(c1O)S2(=O)=O)c1ccccc1
Standard InChI: InChI=1S/C52H44O20P4S4/c53-49-41-21-33(29-73(57,58)37-13-5-1-6-14-37)22-42(49)78(67,68)44-24-35(31-75(61,62)39-17-9-3-10-18-39)26-46(51(44)55)80(71,72)48-28-36(32-76(63,64)40-19-11-4-12-20-40)27-47(52(48)56)79(69,70)45-25-34(23-43(50(45)54)77(41,65)66)30-74(59,60)38-15-7-2-8-16-38/h1-28,53-56H,29-32H2,(H,57,58)(H,59,60)(H,61,62)(H,63,64)
Standard InChI Key: JNCPSODLWJEFQC-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1241.07 | Molecular Weight (Monoisotopic): 1240.0259 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Buldenko VM, Trush VV, Kobzar OL, Drapailo AB, Kalchenko VI, Vovk AI.. (2019) Calixarene-based phosphinic acids as inhibitors of protein tyrosine phosphatases., 29 (6): [PMID:30704811] [10.1016/j.bmcl.2019.01.026] |
Source(1):